Hepatitis B (HBV) vaccine for children and adults 2027-2029 (2029-2030,2030-2031)
Hepatitis B (HBV) vaccine for children and adults 2027-2029 (2029-2030,2030-2031) We did procure this: The Ministry of Social Affairs and Health (hereinafter ”STM”) and the Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Hepatitis B (HBV) Vaccine for children and adults included in the National Vaccination Programme in Finland. The contract period is two (2) years during 2027-2029. The procurement contains two (2) one-year (1) contract period renewals (1+1) to extend the contract for 2029-2030 and 2030-2031. Estimated quantity for the contr…
- Ostaja
- Ministry of Social Affairs and Health
- Julkaistu
- 2026-09-27
- Arvo
- 2 556 000 EUR
- Ilmoitus
- 57930
Voittajat ja hankinnan osat
Hepatitis B (HBV) vaccine for children and adults 2027-2029 (2029-2030,2030-2031)
We did procure this: The Ministry of Social Affairs and Health (hereinafter ”STM”) and the Finnish Institute for Health and Welfare (hereinafter "THL" or “Customer” ) request your tender for Hepatitis B (HBV) Vaccine for children and adults included in the National Vaccination Programme in Finland. The contract period is two (2) years during 2027-2029. The procurement contains two (2) one-year (1) contract period renewals (1+1) to extend the contract for 2029-2030 and 2030-2031. Estimated quan…
- GlaxoSmithKline Oy (0108378-4) – 2 556 000 €